Company profile
BIO-PATH HOLDINGS, INC. CIK 1133818
Ticker
BPTH (OTC)
Industry
Pharmaceutical Preparations
Headquarters
Bellaire, TX 77401
Fiscal year end
2024 (FY)
Key Financials
Revenue
—
Net income
-$9.89M
Total assets
$3.88M
Total liabilities
$3.73M
Stockholders' equity
$154.0K
Cash & equivalents
$1.17M
Operating income
-$11.99M
Operating cash flow
-$10.58M
Capital expenditures
—
Fiscal year 2024, via 10-K filed 2025-03-27. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
96.0%
Equity / assets
4.0%
CapEx / revenue
—
Operating cash flow / net income
1.07×
Derived from the fiscal year 2024 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2024
—
-$9.89M
$3.88M
$3.73M
$154.0K
2023
—
-$16.08M
$3.22M
$2.78M
$441.0K
2022
—
-$13.87M
$15.97M
$1.80M
$14.17M
2021
—
-$10.44M
$26.57M
$1.11M
$25.46M
2020
—
-$10.88M
$16.48M
$1.41M
$15.07M
Company Details
SIC code
2834
State of incorporation
WY
Active filer
Yes
Most recent SEC filing
Form 1-SA
2026-08-20
Financials filed via
Form 10-K
filed 2025-03-27
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Bellaire, TX 77401
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:56 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.